Leaderboard

En | De
No articles selected!     View Cart  
You are here: Dermatology » Psoriasis 12. December 2025
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 1360  Previews Next
   
   Articles 1 - 20 / 27183  
   
AI02 (P002) Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data.
Br J Dermatol
Hussain AB, Iqbal W, Atallah C, Warren RB, Barnes M, Missier P, Reynolds NJ.
PMID: 41382937 [PubMed - indexed for MEDLINE]


P091 Posterior reversible encephalopathy syndrome (PRES) presenting in a patient with psoriasis receiving ustekinumab.
Br J Dermatol
Smith K, Ogg A, Prasad K, Colgan J, Glen C.
PMID: 41382929 [PubMed - indexed for MEDLINE]


P082 The WHO-5 wellbeing measure as an assessment tool in inflammatory skin diseases.
Br J Dermatol
Pender E, Killion L, Hughes R, Kirby B.
PMID: 41382927 [PubMed - indexed for MEDLINE]


P050 Impact of weight-loss interventions on psoriasis severity: a systematic review and meta-analysis.
Br J Dermatol
Morrow S, Scragg J, Hawkins P, Tektonidis TG, Harriss E, Griffiths C, Jebb S.
PMID: 41382908 [PubMed - indexed for MEDLINE]


P115 Long-term outcomes of biologic-naive and biologic-experienced patients, with a focus on women of childbearing age with chronic plaque psoriasis treated with certolizumab pegol.
Br J Dermatol
Makrygeorgou A, McCabe C, Spanopoulos D, Wu K.
PMID: 41382884 [PubMed - indexed for MEDLINE]


P003 Predictors of differential treatment response between adalimumab and methotrexate in psoriasis: a causal forest analysis of the British Association of Dermatologists Biologics and Immunomodulators Register.
Br J Dermatol
Haw WWY, Alabas OA, Sperrin M, Cina G, Abu-Hanna A, Warren RB.
PMID: 41382773 [PubMed - indexed for MEDLINE]


PA12 Evaluating how we manage our paediatric patients with eczema and psoriasis with systemic agents, and identifying barriers to research registry recruitment.
Br J Dermatol
Ali Z, McPherson T.
PMID: 41382762 [PubMed - indexed for MEDLINE]


O07 Serious infection risk with systemic treatments for psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
Br J Dermatol
Bright HRB, Lunt M, Warren RB, Yiu ZZN.
PMID: 41382734 [PubMed - indexed for MEDLINE]


P099 Spesolimab use in effective treatment of generalized pustular psoriasis: a case report.
Br J Dermatol
Santhosh SH, McMullen E, Hunter HJA, Kleyn E, Young HS, Yiu ZZN, Warren RB, Foulkes A.
PMID: 41382699 [PubMed - indexed for MEDLINE]


P100 Effectiveness of risankizumab in biologic-naive and biologic-experienced patients with psoriasis: real-world data from the BADBIR registry.
Br J Dermatol
Shams K, Mounsey S, Sharma K, Jadeja A.
PMID: 41382698 [PubMed - indexed for MEDLINE]


DP03 Psoriasiform lesions in a patient with pulmonary disease.
Br J Dermatol
Gupta P, Chatterjee D, Keshavamurthy V.
PMID: 41382694 [PubMed - indexed for MEDLINE]


O05 A retrospective review of cases of psoriasis requiring discontinuation of biologic therapy from 2007 to 2024 in a multisite NHS trust.
Br J Dermatol
Kim Y, Tan DYL, Bewley A, Mohandas P, Mehrtens S.
PMID: 41382682 [PubMed - indexed for MEDLINE]


P002 Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data.
Br J Dermatol
Hussain AB, Iqbal W, Atallah C, Warren RB, Barnes M, Missier P, Reynolds NJ.
PMID: 41382681 [PubMed - indexed for MEDLINE]


P101 Janus kinase inhibitors in palmoplantar pustulosis: a systematic review and meta-analysis of comorbidity burden to inform a feasibility trial's design (JAKPPPOT).
Br J Dermatol
Gleeson D, Corbett M, Choy SP, Jiang T, Lee J, Bechman K, Russell M, Barker JN, Galloway J, Smith C, Mahil S.
PMID: 41382677 [PubMed - indexed for MEDLINE]


P116 Patient characteristics of biologic-experienced and biologic-naive patients with chronic plaque psoriasis receiving bimekizumab.
Br J Dermatol
Foulkes A, McCabe C, Spanopoulos D, Shams K, Gkini MA.
PMID: 41382638 [PubMed - indexed for MEDLINE]


DP10 Are all Sweet's Sweet?
Br J Dermatol
Sankey SM, Wong A, Mudaliar V, Paul M.
PMID: 41382630 [PubMed - indexed for MEDLINE]


BG03 Biologics for psoriasis in the older patient: profiles, pitfalls and practicalities.
Br J Dermatol
Gawkrodger D.
PMID: 41382581 [PubMed - indexed for MEDLINE]


PA25 Developing an online diagnostic criteria questionnaire for psoriasis in children (< 18 years) using framework analysis from think-aloud cognitive interviews (DIPSOC-QI study).
Br J Dermatol
Cunliffe A, Hughes C, Leighton P, Vaughan E, Naldi L, Rangaraj S, Murphy R, Burden-Teh E.
PMID: 41382577 [PubMed - indexed for MEDLINE]


BI23 Atopic dermatitis and psoriasis in a patient with HIV: a unique immunological phenomenon.
Br J Dermatol
Alghamdi YS, Basendwh M, Alqurashi W, Abdulhafeez D, Alesa D.
PMID: 41382563 [PubMed - indexed for MEDLINE]


BI28 A rare case of cutaneous leishmaniasis associated with guselkumab.
Br J Dermatol
Chiang YH, Winter S, Kalavala M.
PMID: 41382561 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 27183    Page 1 of 1360  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1